11.06
前日終値:
$11.13
開ける:
$11.09
24時間の取引高:
27,306
Relative Volume:
0.10
時価総額:
$552.76M
収益:
$62.02M
当期純損益:
$-45.65M
株価収益率:
-12.02
EPS:
-0.92
ネットキャッシュフロー:
$-9.60M
1週間 パフォーマンス:
-1.73%
1か月 パフォーマンス:
+4.49%
6か月 パフォーマンス:
+5.59%
1年 パフォーマンス:
+8.28%
Theravance Biopharma Inc Stock (TBPH) Company Profile
名前
Theravance Biopharma Inc
セクター
電話
650-808-6000
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TBPH
Theravance Biopharma Inc
|
11.05 | 565.02M | 62.02M | -45.65M | -9.60M | -0.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.72 | 122.48B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.97 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
327.26 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.49 | 31.91B | 3.81B | -644.79M | -669.77M | -6.24 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-08-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
2024-04-12 | 開始されました | BTIG Research | Buy |
2024-01-08 | ダウングレード | Evercore ISI | Outperform → In-line |
2022-05-23 | 開始されました | SVB Leerink | Outperform |
2021-11-05 | アップグレード | JP Morgan | Underweight → Neutral |
2021-09-15 | ダウングレード | JP Morgan | Overweight → Underweight |
2021-08-25 | ダウングレード | Morgan Stanley | Overweight → Underweight |
2021-08-24 | ダウングレード | Cowen | Outperform → Market Perform |
2020-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-07-07 | 開始されました | JP Morgan | Overweight |
2020-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
2020-05-13 | 開始されました | Cowen | Outperform |
2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
2019-11-06 | アップグレード | Robert W. Baird | Underperform → Neutral |
2019-10-29 | 開始されました | H.C. Wainwright | Buy |
2018-03-29 | 再開されました | Piper Jaffray | Overweight |
2017-08-17 | 開始されました | Evercore ISI | Outperform |
2017-06-16 | 開始されました | Cantor Fitzgerald | Overweight |
2017-05-11 | 繰り返されました | Needham | Buy |
2016-12-21 | 開始されました | Needham | Buy |
2016-11-03 | 開始されました | Piper Jaffray | Overweight |
2016-10-12 | ダウングレード | Robert W. Baird | Neutral → Underperform |
2016-08-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2016-06-20 | 開始されました | Guggenheim | Buy |
2016-06-20 | 繰り返されました | Leerink Partners | Outperform |
2016-05-12 | 開始されました | Leerink Partners | Outperform |
2016-05-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
2015-02-03 | アップグレード | Robert W. Baird | Underperform → Neutral |
すべてを表示
Theravance Biopharma Inc (TBPH) 最新ニュース
Why Theravance Biopharma Inc. stock attracts strong analyst attentionWealth Accumulation Stock List - Newser
Is Theravance Biopharma Inc. a good long term investmentRecord-breaking gains - PrintWeekIndia
What analysts say about Theravance Biopharma Inc. stockUnbelievable profit margins - PrintWeekIndia
Theravance Biopharma Inc. Stock Analysis and ForecastExceptional trading results - Autocar Professional
Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizen Tribune
What drives Theravance Biopharma Inc. stock priceConsistent triple-digit returns - jammulinksnews.com
How Theravance Biopharma Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail
Theravance Biopharma SVP Farnum sells $113,869 in stock By Investing.com - Investing.com Nigeria
Theravance Biopharma SVP Farnum sells $113,869 in stock - Investing.com
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats - The Globe and Mail
What makes Theravance Biopharma Inc. stock price move sharplyStrategic High Profit Opportunities - Newser
Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma - Insider Monkey
Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) Target Price at $16.60 - Defense World
Theravance Biopharma SVP Sells 7,000 Shares for $78,000 on July 14, 2025. - AInvest
Theravance higher as China approves Viatris-partnered COPD therapy - MSN
Theravance Biopharma (NASDAQ:TBPH) Downgraded to “Hold” Rating by Wall Street Zen - Defense World
Theravance Biopharma, Inc.(NasdaqGM:TBPH) dropped from Russell 2000 Defensive Index - MarketScreener
Theravance Biopharma, Inc.(NasdaqGM: TBPH) added to Russell Microcap Growth Index - MarketScreener
Theravance Biopharma (NASDAQ:TBPH) Given New $25.00 Price Target at BTIG Research - Defense World
TBPH Stock Price Target Increased Following Milestone Payment | TBPH Stock News - GuruFocus
JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛
Theravance Biopharma price target raised to $25 by BTIG on China approval - Investing.com
Is Theravance Biopharma, Inc. technically bullish or bearish? - MarketsMojo
Theravance Biopharma (NASDAQ:TBPH) Now Covered by Jones Trading - Defense World
Theravance Biopharma (NASDAQ:TBPH) Stock Rating Upgraded by Jones Trading - Defense World
Theravance Biopharma Inc (TBPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):